Home - Products - Others - Other Targets - 4-(2-fluorophenyl)-2,3-dihydro-1,3-thiazol-2-one

4-(2-fluorophenyl)-2,3-dihydro-1,3-thiazol-2-one

CAS No. 1095051-79-8

4-(2-fluorophenyl)-2,3-dihydro-1,3-thiazol-2-one ( —— )

Catalog No. M28391 CAS No. 1095051-79-8

4-(2-fluorophenyl)-2,3-dihydro-1,3-thiazol-2-one is a chemical compound.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 48 Get Quote
10MG 71 Get Quote
25MG 122 Get Quote
50MG 178 Get Quote
100MG 268 Get Quote
200MG 411 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    4-(2-fluorophenyl)-2,3-dihydro-1,3-thiazol-2-one
  • Note
    Research use only, not for human use.
  • Brief Description
    4-(2-fluorophenyl)-2,3-dihydro-1,3-thiazol-2-one is a chemical compound.
  • Description
    4-(2-fluorophenyl)-2,3-dihydro-1,3-thiazol-2-one is a chemical compound.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    GSK-3β
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1095051-79-8
  • Formula Weight
    195.2
  • Molecular Formula
    C9H6FNOS
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Fc1ccccc1-c1csc(=O)[nH]1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Sivaprakasam P, et al. Discovery of new acylaminopyridines as GSK-3 inhibitors by a structure guided in-depth exploration of chemical space around a pyrrolopyridinone core. Bioorg Med Chem Lett. 2015 May 1;25(9):1856-63.
molnova catalog
related products
  • Pseudolaric acid A-O...

    Pseudolaric acid A-O-beta-D-glucopyranoside is a natural product with antibacterial, anticancer.

  • CAY10465

    CAY 10465 is a selective and high-affinity AhR agonist, with a Ki of 0.2 nM, and shows no effect on estrogen receptor (Ki >100000 nM).

  • Cyanidin-3,5-O-diglu...

    Cyanidin-3,5-O-diglucoside chloride has antioxidant activity. Cyanidin-3,5-O-diglucoside inhibits hyperbaric pressure-induced GLAST decrease and can be used in glaucoma studies.